![Anders Jacobson](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Anders Jacobson
Directeur/Membre du Conseil chez
KLARIA PHARMA HOLDING AB
Fortune : 8 595 $ au 31/05/2026
Profil
Anders Jacobson is currently the Deputy Chairman at MD Biomedical AB. He is also an Independent Director at Klaria Pharma Holding AB and the Chief Innovation Officer at Senzime AB. Previously, he served as a Director at Acarix AB from 2020 to 2021.
Mr. Jacobson holds a graduate degree from the University of Uppsala.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
SENZIME AB 0,01% | 31/12/2024 | 16 000 ( 0,01% ) | 8 595 $ | 31/05/2026 |
Postes actifs de Anders Jacobson
| Sociétés | Poste | Début |
|---|---|---|
| SENZIME AB | Corporate Officer/Principal | 01/02/2022 |
| KLARIA PHARMA HOLDING AB | Directeur/Membre du Conseil | 01/01/2022 |
MD Biomedical AB
 MD Biomedical AB Medical/Nursing ServicesHealth Services Provides micro dialysis products and services | Directeur/Membre du Conseil | - |
Anciens postes connus de Anders Jacobson
| Sociétés | Poste | Fin |
|---|---|---|
| ACARIX AB | Directeur/Membre du Conseil | 11/05/2021 |
Formation de Anders Jacobson
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
10
Relations au 1er degré
5
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 5 |
|---|---|
Senzime AB
 Senzime AB Medical SpecialtiesHealth Technology Develops and markets an enzyme based biosensor technology | Health Technology |
University of Uppsala
 University of Uppsala Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Acarix AB
 Acarix AB Medical SpecialtiesHealth Technology Provides medical device for monitoring Coronary Artery Disease | Health Technology |
Klaria Pharma Holding AB
 Klaria Pharma Holding AB Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals | Health Technology |
MD Biomedical AB
MD Biomedical AB Medical/Nursing ServicesHealth Services Provides micro dialysis products and services | Health Services |
